Results
1 -
10 of
10
(Click
here to explore results)
- Ion Channel Drug Discovery, CHAPTER 6 AMPA Receptor Positive Allosteric Modulators – a Case History. Simon E Ward
, 2015
, Pages 105-134
- Drug Discovery for Psychiatric Disorders, CHAPTER 5 Discovery and Clinical Data for a Novel AMPA Receptor Positive Modulator. Simon E. Ward
, 2012
, Pages 99-122
- Allosterism in Drug Discovery, CHAPTER 14 Development of AMPA Receptor Modulators as Cognition Enhancers. Craig Jamieson, Emma L. Duffy
, 2017
, Pages 310-333
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 9 Heterocycles Containing Nitrogen and Sulfur as Potent Biologically Active Scaffolds. Ana Martinez, Carmen Gil
, 2016
, Pages 231-261
- Ion Channel Drug Discovery, Subject Index
, 2015
, Pages 355-366
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders. Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley
, 2012
, Pages 258-275
- Acute Brain Impairment: Scientific Discoveries and Translational Research, Chapter 9 Advances in Diagnostics and Treatment of Neurotoxicity after Sports-related Injuries. Thomas A. Gennarelli, Svetlana A. Dambinova, Joseph D. Weissman
, 2018
, Pages 141-161
- Drug Discovery for Schizophrenia, CHAPTER 6 Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia. Catharine A. Mielnik, Amy J. Ramsey
, 2015
, Pages 115-140
- Drug Discovery for Psychiatric Disorders, CHAPTER 4 Glutamatergic Approaches for the Treatment of Schizophrenia. John A. Morrow, Robert Gilfillan, Stuart A. Neale
, 2012
, Pages 56-98
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 5 Sulfonamide as an Essential Functional Group in Drug Design. Amit S. Kalgutkar, Rhys Jones, Aarti Sawant
, 2010
, Pages 210-274